These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12054086)

  • 21. Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments.
    Galimberti D; Bresolin N; Scarpini E
    Expert Rev Neurother; 2004 May; 4(3):439-53. PubMed ID: 15853541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts.
    Fahmy NM; Yamani MH; Starling RC; Ratliff NB; Young JB; McCarthy PM; Feng J; Novick AC; Fairchild RL
    Transplantation; 2003 Jun; 75(12):2044-7. PubMed ID: 12829909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of chemokines in acute renal allograft rejection and chronic allograft injury.
    Fischereder M; Schroppel B
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1807-14. PubMed ID: 19273164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression and function of chemokines involved in CNS inflammation.
    Ubogu EE; Cossoy MB; Ransohoff RM
    Trends Pharmacol Sci; 2006 Jan; 27(1):48-55. PubMed ID: 16310865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of chemokines in transplant graft arterial disease.
    Shimizu K; Mitchell RN
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1937-49. PubMed ID: 18802020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early up-regulation of CXC-chemokine expression is associated with strong cellular immune responses to murine skin xenografts.
    Lee EM; Park JO; Kim D; Kim JY; Oh KH; Park CG; Oh BH; Kim S; Ahn C
    Xenotransplantation; 2006 Jul; 13(4):328-36. PubMed ID: 16768726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokines as therapeutic targets in renal inflammation.
    Rovin BH
    Am J Kidney Dis; 1999 Oct; 34(4):761-4; discussion 765-7. PubMed ID: 10516362
    [No Abstract]   [Full Text] [Related]  

  • 29. Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival.
    Pillai RG; Beutelspacher SC; Larkin DF; George AJ
    Transplantation; 2008 Jun; 85(11):1640-7. PubMed ID: 18551072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.
    Suresh P; Wanchu A
    J Postgrad Med; 2006; 52(3):210-7. PubMed ID: 16855325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.
    Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S
    J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combined organ effect: protection against rejection?
    Rana A; Robles S; Russo MJ; Halazun KJ; Woodland DC; Witkowski P; Ratner LE; Hardy MA
    Ann Surg; 2008 Nov; 248(5):871-9. PubMed ID: 18948817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X; Oppenheim JJ; Howard OM
    Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection.
    Pescovitz MD
    Clin Transplant; 2006; 20(1):48-54. PubMed ID: 16556153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
    Hoffmann U; Segerer S; Rümmele P; Krüger B; Pietrzyk M; Hofstädter F; Banas B; Krämer BK
    Nephrol Dial Transplant; 2006 May; 21(5):1373-81. PubMed ID: 16421159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokines in the pathogenesis of vascular disease.
    Charo IF; Taubman MB
    Circ Res; 2004 Oct; 95(9):858-66. PubMed ID: 15514167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokines in transplantation: what can atypical receptors teach us about anti-inflammatory therapy?
    O'Boyle G; Ali S; Kirby JA
    Transplant Rev (Orlando); 2011 Oct; 25(4):136-44. PubMed ID: 21514134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokines: directing leukocyte infiltration into allografts.
    el-Sawy T; Fahmy NM; Fairchild RL
    Curr Opin Immunol; 2002 Oct; 14(5):562-8. PubMed ID: 12183154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemokines and leukocyte traffic.
    Baggiolini M
    Nature; 1998 Apr; 392(6676):565-8. PubMed ID: 9560152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of chemokines and chemokine receptors in progressive renal diseases.
    Segerer S
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S15-8. PubMed ID: 12612944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.